We may have changed our name, but our top quality service remains the same.
As many of you know, Paragon International has produced successful pre-FDA meetings for the past 22 years. We’ve learned a thing or two over the years, like the fact that most clinical trials fail to retain enough participants. With an average dropout rate of nearly 1 in 4 participants, keeping them on a protocol is about more than compliance. Increased retention means building participant expectations into the protocol to minimize inefficiencies and burdens.
Now we’re using this knowledge to make your clinical trial more successful!
Paragon Global CRS now has a team of highly trained and experienced clinical research specialists who are fully prepared to work exclusively with study sites and their trial participants. Our dedicated team works to secure the many services necessary to ensure that both compliance and retention rates are maintained at a high level.
We help participants with transportation to clinical sites and help eliminate financial burdens to reduce withdrawal rates and enhance the participant’s overall experience. The Paragon Team can also secure housing, drug delivery, and participation surveys.
Contact Paragon Global CRS today to determine how we can help you improve participant experiences and retention.
See what else is new at Paragon!
The Antidote CRS Platform is a reliable and cost-effective support system to help CROs reach clinical trial milestones by increasing participant retention and satisfaction. It was designed by the clinical research specialists at Paragon Global CRS in order to help clinical research organizations manage expense reimbursements, stipend management, drug delivery, and participant surveys.
Paragon Global CRS opens European Headquarters! We conveniently have offices located in North America and Europe to better serve our global clients and their needs. Contact us at either location for questions regarding pharmaceutical meetings and clinical trial support services.
At Paragon Global CRS, we have always been focused on providing services that foster participant-centric clinical trials because we care, and that will never change.